Drug product
mitoXANTRONE Injection USP (concentrate), 20 mg/10 mL (2 mg/mL), 10 mL Multiple Dose Vial, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-4685-01.
D-0095-2017
Product summary
- Event
- Event 75236
- Status
- Terminated
- Classification
- Class III
- Quantity
- 11,214 vials
- Official record key
drug-enforcement:D-0095-2017
Official wording
Reason: Failed Impurities/Degradation Specifications: potential failure to meet the specification for Impurity D throughout shelf-life.
Code information: Lot Numbers: 31318574B, Exp 09/16; 31319610B, Exp 07/17; 31320058B, Exp 11/17; 31320497B, Exp 12/17; 31320744B, Exp 02/18
Distribution pattern: Nationwide
Derived failure modes
-
Potency or specification failure
Failed Impurities/Degradation Specifications